Timothy Chan, M.D., Ph.D., chair of Cleveland Clinic‘s International Heart for Immunotherapy and Precision Immuno-Oncology and Sheikha Fatima Bint Mubarak Endowed Chair in Immunotherapy and Precision Immuno-Oncology, has been elected to the Nationwide Academy of Medication (NAM), one of many highest honors within the fields of well being and medication.
The Nationwide Academy of Medication acknowledges people who’ve demonstrated excellent skilled achievement and dedication to service. New members are elected by present members by means of a course of that acknowledges people who’ve made main contributions to the development of the medical sciences, healthcare and public well being.
A famend immuno-oncology and most cancers genomics skilled, Dr. Chan joined Cleveland Clinic in 2020 to discovered and lead the International Heart for Immunotherapy and Precision Immuno-Oncology, which brings collectively multidisciplinary specialists from throughout the worldwide well being system to advance analysis and therapy associated to the quickly rising discipline of immuno-oncology.
“Tim is a pioneer in most cancers genomics and immuno-oncology and is really deserving of this prestigious honor,” stated Serpil Erzurum, M.D., Cleveland Clinic Chief Analysis and Tutorial Officer. “Beneath his management, we’re already seeing how immunotherapy is revolutionizing therapy for a lot of forms of most cancers. As a clinician, researcher and innovator, he has impressed and enabled clinicians and scientists all through the enterprise to advance customized most cancers care and transfer promising new therapies into affected person care.”
Dr. Chan is a workers member within the Division of Radiation Oncology of the Cleveland Clinic Taussig Most cancers Institute. He’s additionally professor of medication, co-director of the Nationwide Heart for Regenerative Medication of Case Western Reserve College and co-leader of the Immune Oncology Program, Case Complete Most cancers Heart.
Dr. Chan’s analysis lab investigates the genomic and immunologic drivers of tumor improvement and therapy response, with particular curiosity in tumor immunology and immunotherapy improvement. He has printed over 280 articles in peer-reviewed journals, made landmark discoveries in his discipline and obtained quite a few awards, together with the Nationwide Most cancers Institute Excellent Investigator Award in 2018.
Dr. Chan joined Cleveland Clinic from Memorial Sloan Kettering Most cancers Heart and Weill Cornell College of Medication, the place he led the Immunogenomics and Precision Oncology Platform and was a tenured professor, the Paine Webber Chair, and the Translational Oncology Division chair.
Dr. Chan earned his M.D. and Ph.D. in genetics from Johns Hopkins College, the place he additionally accomplished a residency in radiation oncology and a postdoctoral fellowship within the division of tumor biology. He’s board licensed in radiation oncology and is an elected member of the Affiliation of American Physicians (AAP).
“It’s my honor to welcome this really distinctive class of latest members to the Nationwide Academy of Medication,” stated NAM President Victor J. Dzau M.D. “Their contributions to well being and medication are unparalleled, and their management and experience will likely be important to serving to the NAM sort out right now’s pressing well being challenges, inform the way forward for well being care, and guarantee well being fairness for the advantage of throughout the globe.”
The NAM is nicely represented by Cleveland Clinic workers. Among the many many distinguished physicians and scientists elected are: the late Irvine H. Web page, M.D. (1970), first chair of the Division of Analysis; the late Bernadine P. Healy, M.D. (1987), former chair of the Lerner Analysis Institute; George R. Stark, Ph.D. (2002), former chair of the Lerner Analysis Institute; Toby Cosgrove, M.D. (2013), former Cleveland Clinic CEO and President; Charis Eng, M.D., Ph.D. (2010), founding chair of the Genomic Medication Institute; Stanley Hazen, M.D., Ph.D. (2016), chair of Cardiovascular and Metabolic Sciences; and Dr. Erzurum (2017).